PHP ED denied as not FDA-approved for this use by Cigna?

Cigna's specific coverage criteria for php ed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Issue a "Not FDA-Approved" Denial for PHP/ED — and How to Appeal

A "not FDA-approved" denial applied to a Partial Hospitalization Program or Eating Disorder treatment service is almost always a misclassification. The FDA does not "approve" behavioral health programs or levels of care the way it approves drugs or devices — PHP is a healthcare service level, not a regulated product. When this denial appears, it most commonly reflects one of two situations: (1) a specific medication used within the eating disorder program is being prescribed for an indication the FDA has not approved (off-label use), or (2) the automated claims-review system has miscategorized the service type.

### Why This Denial Is Appealable

If the denial targets the program itself: the FDA does not regulate clinical programs, so a "not FDA-approved" rationale for PHP as a service has no regulatory basis and should be reversed on that ground alone. Request in writing the exact basis for the classification.

If the denial targets a medication used within the program for an off-label indication: off-label prescribing is legal and common in clinical practice, including in eating disorder care. Many insurers — and courts — recognize that medically accepted off-label use supported by established clinical evidence is a covered benefit. The Mental Health Parity and Addiction Equity Act (MHPAEA) also requires that Cigna's criteria for covering off-label treatments in behavioral health be no more restrictive than for off-label treatments in medical/surgical care.

### Federal Appeal Framework

• Internal appeal: File within the deadline stated in the denial letter. Demand the specific clinical basis for the not-approved determination and the name and specialty of the reviewing clinician.
• External review (ACA §2719 / ERISA §503): Request independent external review within approximately 4 months of the final internal denial. An IRO can determine whether the service or medication represents medically accepted practice.
• Expedited review: Available for acute presentations with immediate medical risk.

### Documentation to Gather

1. Service description clarification — a letter from the PHP program confirming it is a licensed behavioral health program, not an unapproved product. 2. Medication context (if applicable) — the prescriber's letter citing the clinical basis for off-label use, referencing support from the applicable professional society guidelines (by organization). 3. Cigna's denial rationale in full — request the exact regulatory or clinical basis cited so the appeal can address it directly. 4. MHPAEA parity analysis — if Cigna covers comparable off-label treatments in medical care, document that fact.

### Criteria-Mapping Structure

Address the denial's stated basis element by element. If the denial conflates service-level approval with drug approval, highlight the category error explicitly. If it concerns off-label medication use, map the clinical support (guideline organization, standard-of-care letter) to each requirement in Cigna's off-label coverage criteria.